Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Evidence based management guidelines for the detection and treatment of congenital CMV.

Kadambari S, Williams EJ, Luck S, Griffiths PD, Sharland M.

Early Hum Dev. 2011 Nov;87(11):723-8. doi: 10.1016/j.earlhumdev.2011.08.021. Epub 2011 Sep 29.

PMID:
21962770
2.

Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening.

Kawada J, Torii Y, Kawano Y, Suzuki M, Kamiya Y, Kotani T, Kikkawa F, Kimura H, Ito Y.

J Clin Virol. 2015 Apr;65:41-5. doi: 10.1016/j.jcv.2015.01.015. Epub 2015 Jan 23.

PMID:
25766986
3.

Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.

Yilmaz Çiftdogan D, Vardar F.

J Trop Pediatr. 2011 Apr;57(2):132-4. doi: 10.1093/tropej/fmq050. Epub 2010 Jun 24.

PMID:
20576693
4.

Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss.

Williams EJ, Kadambari S, Berrington JE, Luck S, Atkinson C, Walter S, Embleton ND, James P, Griffiths P, Davis A, Sharland M, Clark JE.

Arch Dis Child Fetal Neonatal Ed. 2014 May;99(3):F230-6. doi: 10.1136/archdischild-2013-305276. Epub 2014 Mar 4.

PMID:
24596404
5.

Congenital cytomegalovirus: what the otolaryngologist should know.

Duval M, Park AH.

Curr Opin Otolaryngol Head Neck Surg. 2014 Dec;22(6):495-500. doi: 10.1097/MOO.0000000000000104. Review.

PMID:
25222916
6.

The use of saliva as a practical and feasible alternative to urine in large-scale screening for congenital cytomegalovirus infection increases inclusion and detection rates.

Cardoso ES, Jesus BL, Gomes LG, Sousa SM, Gadelha SR, Marin LJ.

Rev Soc Bras Med Trop. 2015 Mar-Apr;48(2):206-7. doi: 10.1590/0037-8682-0200-2014.

7.

Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus.

Dollard SC, Schleiss MR, Grosse SD.

J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S249-54. doi: 10.1007/s10545-010-9125-3. Epub 2010 Jun 8. Review.

PMID:
20532822
8.

Newborn screening for congenital cytomegalovirus: Options for hospital-based and public health programs.

Grosse SD, Dollard S, Ross DS, Cannon M.

J Clin Virol. 2009 Dec;46 Suppl 4:S32-6. doi: 10.1016/j.jcv.2009.08.019. Epub 2009 Sep 26.

PMID:
19783205
9.

Universal neonatal cytomegalovirus screening using saliva - report of clinical experience.

Barkai G, Ari-Even Roth D, Barzilai A, Tepperberg-Oikawa M, Mendelson E, Hildesheimer M, Kuint J.

J Clin Virol. 2014 Aug;60(4):361-6. doi: 10.1016/j.jcv.2014.04.024. Epub 2014 May 9.

PMID:
24881490
10.

Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection.

Pati SK, Pinninti S, Novak Z, Chowdhury N, Patro RK, Fowler K, Ross S, Boppana S; NIDCD CHIMES Study Investigators.

Pediatr Infect Dis J. 2013 Oct;32(10):1050-4. doi: 10.1097/INF.0b013e31829bb0b9.

11.

Clinically targeted screening for congenital CMV - potential for integration into the National Hearing Screening Programme.

Kadambari S, Luck S, Davis A, Williams E, Berrington J, Griffiths P, Sharland M.

Acta Paediatr. 2013 Oct;102(10):928-33. doi: 10.1111/apa.12335. Epub 2013 Aug 8.

PMID:
23927434
12.

Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection.

Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan RW Jr, Palmer AL, Ahmed A, Michaels MG, Sánchez PJ, Bernstein DI, Britt WJ, Fowler KB; National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study.

JAMA. 2010 Apr 14;303(14):1375-82. doi: 10.1001/jama.2010.423.

13.

Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?

Yamamoto AY, Mussi-Pinhata MM, Marin LJ, Brito RM, Oliveira PF, Coelho TB.

J Clin Virol. 2006 Jul;36(3):228-30. Epub 2006 Jun 5.

PMID:
16750653
14.

Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.

Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sánchez PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Britt WJ, Fowler KB; National Institute on Deafness and Other Communication Disorders CHIMES Study.

N Engl J Med. 2011 Jun 2;364(22):2111-8. doi: 10.1056/NEJMoa1006561.

15.

Screening newborns for congenital cytomegalovirus infection.

Bale JF Jr.

JAMA. 2010 Apr 14;303(14):1425-6. doi: 10.1001/jama.2010.424. No abstract available.

PMID:
20388901
16.

Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns.

Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B, Landini MP, Faldella G.

Pediatrics. 2006 Jan;117(1):e76-83. Epub 2005 Dec 1. Erratum in: Pediatrics. 2006 Apr;117(4):1467.

PMID:
16326692
17.

Neonatal screening for congenital cytomegalovirus infection and hearing loss.

Barbi M, Binda S, Caroppo S, Primache V.

J Clin Virol. 2006 Feb;35(2):206-9. Epub 2005 Dec 27. Review.

PMID:
16384745
18.

Congenital cytomegalovirus infection and hearing loss.

Pass RF.

Herpes. 2005 Oct;12(2):50-5. Review.

PMID:
16209862
19.

Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age.

Hilgendorff A, Daiminger A, Dangel V, Kreuder J, Geidel C, Reiss I, Enders G.

Klin Padiatr. 2009 Dec;221(7):448-9. doi: 10.1055/s-0029-1234076. No abstract available.

PMID:
20013570
20.

Congenital cytomegalovirus infection: clinical outcome.

Boppana SB, Ross SA, Fowler KB.

Clin Infect Dis. 2013 Dec;57 Suppl 4:S178-81. doi: 10.1093/cid/cit629.

Supplemental Content

Support Center